MRNA - Kapitalisasi marang volume dodolan Moderna Inc

Logo korporat perusahaan Moderna Corp (MRNA)

Moderna, Inc. (MRNA) is accelerating vaccine development through AI algorithms and robotic manufacturing. The market capitalization-to-revenue ratio on the GURU.Markets service reflects this trend, with the indicator reaching 37.10. While the digitalization of mRNA synthesis reduces testing timelines, the decline in COVID-related revenues is forcing the company to rapidly deploy new respiratory products to maintain its financial health.

Moderna Corp (MRNA): Rasio rega marang pendapatan saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Moderna Corp (MRNA)

- rega pasar lan target rega analis:
Kutipan saham modernatx.com|MRNA - Target konsensus
- statistik kapitalisasi pasar:
Nilai pasar Moderna Corp|MRNA - Nilai Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Saham Moderna|MRNA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku modernatx.com|MRNA - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas Moderna, Inc.|MRNA - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Moderna Therapeutics|MRNA - Utang perusahaan|Utang marang nilai buku Moderna Corp|MRNA - Utang jangka dawa perusahaan|Utang jangka cendhak Moderna|Rasio likuiditas darurat modernatx.com
- data bathi resik lan rasio valuasi:
MRNA - Bathi resik|Bathi resik sing dikarepake Moderna, Inc.|MRNA - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Moderna Inc|MRNA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Moderna Corp|MRNA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Moderna|MRNA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan modernatx.com|MRNA - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Moderna, Inc.
- data total pendapatan lan volume dodolan:
MRNA - Pendapatan perusahaan|Prakiraan pendapatan perusahaan modernatx.com|MRNA - Multiplikator P/S|Multiplikator forward rega marang pendapatan Moderna Corp
Analisis fundamental perusahaan:MRNA (modernatx.com)
Produk sing diprodhuksi Moderna, Inc.

Investors are assessing the potential of Moderna, Inc. (MRNA) through the market value of a single dollar of revenue, which is critical for capital-intensive biotechnology companies. By analyzing the price-to-sales ratio, you determine the extent of the premium paid for the scalable mRNA platform, where a high valuation is justified by the uniqueness of patents and the barriers to entry for competitors into this technological circuit.

Pesaing Moderna, Inc.

Kapitalisasi marang pendapatan summittxinc.com SMMT|Vaxcyte - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TARS (Tarsus Pharmaceuticals Inc)|CorMedix Corp - Multiplikator P/S|Koefisien rega marang pendapatan Seres Therapeutics, Inc MCRB|Spero Therapeutics (SPRO) - Rasio rega marang pendapatan|Rega marang dodolan SCYNEXIS (SCYX)|Rasio rega marang pendapatan AN2 Therapeutics Inc|Rasio kapitalisasi marang pendapatan PYPD (PolyPid Limited)|Rasio rega marang pendapatan YS Biopharma (LSB)|Koefisien rega marang pendapatan iterumtx.com|Rasio rega marang pendapatan BiomX PHGE|SNGX - Kapitalisasi marang pendapatan|SXTP - Rasio rega marang pendapatan|Rega marang dodolan oragenics.com|OPGN: Multiplikator P/S